Design Therapeutics, Inc. (DSGN)
11.65
+0.16
(+1.39%)
USD |
NASDAQ |
Oct 09, 16:00
11.65
0.00 (0.00%)
After-Hours: 20:00
Design Therapeutics Net Income (Quarterly) : -20.16M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -20.16M |
| March 31, 2026 | -17.64M |
| December 31, 2025 | -16.00M |
| September 30, 2025 | -17.00M |
| June 30, 2025 | -19.08M |
| March 31, 2025 | -17.72M |
| December 31, 2024 | -13.65M |
| September 30, 2024 | -13.04M |
| June 30, 2024 | -11.79M |
| March 31, 2024 | -11.10M |
| December 31, 2023 | -11.84M |
| September 30, 2023 | -15.79M |
| June 30, 2023 | -19.94M |
| Date | Value |
|---|---|
| March 31, 2023 | -19.29M |
| December 31, 2022 | -17.34M |
| September 30, 2022 | -17.70M |
| June 30, 2022 | -15.00M |
| March 31, 2022 | -13.26M |
| December 31, 2021 | -11.06M |
| September 30, 2021 | -11.32M |
| June 30, 2021 | -7.636M |
| March 31, 2021 | -5.514M |
| September 30, 2020 | -2.32M |
| June 30, 2020 | -1.442M |
| March 31, 2020 | -0.663M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Palvella Therapeutics, Inc. | -21.87M |
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 20.16M |
| EPS Diluted (Quarterly) | -0.3226 |
| Enterprise Value | 524.32M |
| Earnings Yield | -10.13% |
| Normalized Earnings Yield | -10.13 |